{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"JCO Article Insights: LEAP-010 Study in Recurrent\/Metastatic Head and Neck Cancer","description":"Host Jake New summarizes and offers insights into the JCO article by Licitra et al., &quot;Pembrolizumab With or Without Lenvatinib as First-Line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Phase III LEAP-010 Study.&quot;  LINK TO FULL TRANSCRIPT ","author_name":"Journal of Clinical Oncology (JCO) Podcast","author_url":"http:\/\/sites.libsyn.com\/58526","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/41033275\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/00457c\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/item\/41033275"}